Array Bio stops study testing drug for ovarian cancer
April 01, 2016 at 09:16 AM EDT
April 1 (Reuters) - Array BioPharma Inc said it was abandoning a late-stage study testing its experimental drug on ovarian cancer patients, after an interim analysis showed the trial would likely fail.